Fusion Antibodies Plc (FAB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,537 | 1,984 | 4,491 | 286 | 414 |
| Inventories | 340 | 243 | 82 | 70 | 0 |
| Other current assets | 925 | 1,079 | 933 | 574 | 278 |
| TOTAL | $2,802 | $3,306 | $5,506 | $930 | $692 |
| Non-Current Assets | |||||
| PPE Net | 1,470 | 1,588 | 547 | 107 | 50 |
| Intangibles | 4 | 6 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,764 | 1,342 | 1,156 | 1,119 | 1,127 |
| TOTAL | $3,238 | $2,937 | $1,703 | $1,226 | $1,177 |
| Total Assets | $6,040 | $6,243 | $7,209 | $2,156 | $1,868 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 415 | 462 | 281 | 246 | 98 |
| TOTAL | $989 | $796 | $570 | $430 | $391 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 20 | 20 | 64 | 20 | 20 |
| TOTAL | $239 | $93 | $64 | $20 | $20 |
| Total Liabilities | $1,228 | $889 | $634 | $450 | $411 |
| Shareholders' Equity | |||||
| Common Shares | 884 | 884 | 884 | 548 | 548 |
| Retained earnings | -944 | -402 | 819 | -5,003 | -5,252 |
| TOTAL | $4,812 | $5,354 | $6,575 | $1,706 | $1,457 |
| Total Liabilities And Equity | $6,040 | $6,243 | $7,209 | $2,156 | $1,868 |